- Home
- Products
- Customized FluoroAb™
- FLAG
- Anti-FLAG MAb (Clone 3)-iFluor® 514 Succinimidyl Ester
Anti-FLAG MAb (Clone 3)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11832)
This product is comprised of an Chimeric Anti-FLAG IgG1-kappa (Clone 3) labeled with iFluor® 514 Succinimidyl Ester. iFluor® 514 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- FLAG
- Overview
- Chimeric Anti-FLAG IgG1-kappa (Clone 3)
- Species Reactivity
- Human
- Name
- iFluor® 514 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 511/527
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-IL2RA MAb (Clone 5)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14899)
- Anti-CD79B MAb (Clone 12)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8508)
- Anti-TNF MAb (Clone 14)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13819)
- Anti-TNFRSF8 MAb (Clone 6)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11129)
- Anti-NGF MAb (Clone 8)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2975)
- Anti-CD2 MAb (Clone 12)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2647)
- Anti-GD2 MAb (Clone 1)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13033)
- Anti-OxLDL MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11509)
- Anti-KDR MAb (Clone 5)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14856)
- Anti-F3 MAb (Clone 7)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5471)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS11832. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-585 | Anti-FLAG-SPDP-NCS ADC | SPDP(N-succinimidyl 3-[2-pyridyldithio]-propionate) | NCS |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.